Hi lemoncat, I kind of expected GILEAD to come in to buy B. The reason is Gilead regularly buys smaller pharmaceutical companies. Plus they own REMDESIVIR. Narayanan seminar presentation will talk to Remdesivir and Brilacidin. All of which suggest Gilead. Imo
They are working on a subcutaneous delivery for keytruda to extend the patent but if we have great results I wouldn’t be opposed to being acquired by them.